We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized ... PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies. Show more
As filed with the Securities and Exchange Commission on March 6, 2024 Registration No. 333- UNITED STATES SECURITIES...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANTTO SECTION 12(b) OR (g) OF THE SECURITIES...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 POLYPID LTD. (Name of Issuer) Common Shares (Title of Class of...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR...
As filed with the Securities and Exchange Commission on February 1, 2024 Registration No. 333- UNITED STATES SECURITIES...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1 | 2.22222222222 | 4.5 | 5.5 | 4.41 | 2646 | 4.99211294 | CS |
4 | -1.18 | -20.4152249135 | 5.78 | 6 | 4.41 | 1563 | 5.16426785 | CS |
12 | -2.13 | -31.6493313522 | 6.73 | 9.2 | 4.41 | 4536 | 6.38266039 | CS |
26 | -0.03 | -0.647948164147 | 4.63 | 9.2 | 3.5655 | 5505 | 5.35844931 | CS |
52 | -9.5 | -67.3758865248 | 14.1 | 14.7 | 3.5655 | 57240 | 10.36490459 | CS |
156 | -280.4 | -98.3859649123 | 285 | 303 | 3.5655 | 149540 | 54.04435101 | CS |
260 | -475.4 | -99.0416666667 | 480 | 583.5 | 3.5655 | 132109 | 86.80446029 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions